Related Experiment Videos
Minimal ventilation to prevent bronchopulmonary dysplasia in extremely-low-birth-weight infants
Waldemar A Carlo1, Ann R Stark, Linda L Wright
1University of Alabama at Birmingham, Division of Neonatology, 35233, USA.
Insights
Minimal ventilation did not decrease death or bronchopulmonary dysplasia (BPD) in premature infants. However, it significantly reduced the need for ventilator support at 36 weeks, suggesting potential benefits for further investigation.
Area of Science:
- Neonatal Medicine
- Pediatric Critical Care
- Respiratory Physiology
Background:
- Bronchopulmonary dysplasia (BPD) and mortality remain significant challenges in extremely preterm infants.
- Mechanical ventilation strategies aim to minimize lung injury while supporting respiratory function.
- The optimal ventilation strategy for very low birth weight infants is still under investigation.
Purpose of the Study:
- To evaluate the efficacy of a minimal ventilation strategy compared to routine ventilation in reducing death or BPD in infants with birth weight 501-1000g.
- To assess the impact of dexamethasone therapy in conjunction with ventilation strategies.
Main Methods:
- A 2x2 factorial randomized controlled trial was conducted.
- Infants were assigned to either minimal ventilation (PCO2 target >52 mm Hg) or routine ventilation (PCO2 target <48 mm Hg).
- Participants also received either dexamethasone or a saline placebo for 10 days.
Main Results:
- The trial was halted early due to adverse events associated with dexamethasone.
- No significant difference was found in the primary outcome of death or BPD between minimal and routine ventilation groups (RR 0.93, 95% CI 0.77-1.12).
- Significantly lower rates of ventilator support at 36 weeks were observed in the minimal ventilation group (1% vs 16%, P <.01).
Conclusions:
- Minimal ventilation, as studied, did not reduce the incidence of death or BPD in this cohort.
- The observed reduction in ventilator support suggests that minimal ventilation may be a beneficial strategy for preterm infants.
- Further research is warranted to explore the potential of minimal ventilation strategies.
Objective:
To determine whether minimal ventilation decreases death or bronchopulmonary dysplasia (BPD).
Study Design:
Infants with birth weight 501 g to 1000 g and mechanically ventilated before 12 hours were randomly assigned to minimal ventilation (partial pressure of carbon dioxide [PCO(2)] target >52 mm Hg) or routine ventilation (PCO(2) target <48 mm Hg) and a tapered dexamethasone course or saline placebo for 10 days, using a 2 x 2 factorial design. The primary outcome was death or BPD at 36 weeks' postmenstrual age.
Results:
After enrollment of 220 patients, the trial was halted because of unanticipated nonrespiratory adverse events related to dexamethasone therapy. The relative risk for death or BPD at 36 weeks in the minimal versus routine ventilation groups was 0.93 (95% CI, 0.77-1.12; P =.43). Ventilator support at 36 weeks was 1% in the minimal versus 16% in the routine group (P <.01). Major morbidities and long-term outcome were comparable in both treatment groups.
Conclusions:
With the sample size studied, minimal ventilation did not reduce the incidence of death or BPD. The reduced ventilator support at 36 weeks in the minimal ventilation group warrants further study of this intervention.